Organizer

Elisa Panada, Scientific editor, Cell Reports Medicine, Cell Press

Elisa Panada

Elisa obtained her PhD in Systems Biology at the University College Dublin, with a thesis on the role of RAF dimers in therapy resistant malignant melanoma. In 2019, she moved to the Wellcome Sanger Institute (Cambridge, UK) to study the role of the tumour microenvironment in NSCLC by using single-cell technologies. In 2021 she joined PLOS ONE as an Associate Editor, before moving to Cell Reports Medicine in April 2022.

« Go Back

Register Here Submit Abstract